Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ritter

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Immunology Letters|July 25, 2016
Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cellsAndreia Ribeiro, Thomas Ritter, Matthew Griffin, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft RejectionOliver Treacy, Gerry Fahy, Thomas Ritter, et al.
Human Gene Therapy|August 20, 2010
Immunological aspects of allogeneic mesenchymal stem cell therapiesMatthew D Griffin, Thomas Ritter, Bernard P Mahon
Immunology Letters|November 14, 2016
Corrigendum to: "Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cells" [J. Immunol. Lett. 177 (2016) 38-46]Andreia Ribeiro, Thomas Ritter, Matthew Griffin, et al.
Planta Medica|October 8, 2009
Benzopyranones and their sulfate esters from Pelargonium sidoidesHermann Hauer, Stefan Germer, Jens Elsässer, et al.
Progress in Retinal and Eye Research|December 21, 2024
Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVsManon Jammes, Abbas Tabasi, Trung Bach, et al.
Journal of Translational Medicine|March 4, 2026
Quantitative evaluation of mesenchymal stromal cell immunomodulatory potency and cost-effectiveness of cytokine licensing for translational applicationDehua Liao, Jing Wen, Thomas Ritter, et al.
Ophthalmic Research|November 30, 2007
Effects of spironolactone on corneal allograft survival in the ratLjiljana Otasevic, Nianqiao Gong, Thomas Ritter, et al.
Molecular Vision|April 7, 2009
Corneal allograft endothelial cell replacement represents a reparative response to transplant injuryNianqiao Gong, Uwe Pleyer, Thomas Ritter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2015
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic ApplicationsSweta Rani, Aideen E Ryan, Matthew D Griffin, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Immunology Letters|July 25, 2016
Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cellsAndreia Ribeiro, Thomas Ritter, Matthew Griffin, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft RejectionOliver Treacy, Gerry Fahy, Thomas Ritter, et al.
Human Gene Therapy|August 20, 2010
Immunological aspects of allogeneic mesenchymal stem cell therapiesMatthew D Griffin, Thomas Ritter, Bernard P Mahon
Immunology Letters|November 14, 2016
Corrigendum to: "Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cells" [J. Immunol. Lett. 177 (2016) 38-46]Andreia Ribeiro, Thomas Ritter, Matthew Griffin, et al.
Planta Medica|October 8, 2009
Benzopyranones and their sulfate esters from Pelargonium sidoidesHermann Hauer, Stefan Germer, Jens Elsässer, et al.
Progress in Retinal and Eye Research|December 21, 2024
Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVsManon Jammes, Abbas Tabasi, Trung Bach, et al.
Journal of Translational Medicine|March 4, 2026
Quantitative evaluation of mesenchymal stromal cell immunomodulatory potency and cost-effectiveness of cytokine licensing for translational applicationDehua Liao, Jing Wen, Thomas Ritter, et al.
Ophthalmic Research|November 30, 2007
Effects of spironolactone on corneal allograft survival in the ratLjiljana Otasevic, Nianqiao Gong, Thomas Ritter, et al.
Molecular Vision|April 7, 2009
Corneal allograft endothelial cell replacement represents a reparative response to transplant injuryNianqiao Gong, Uwe Pleyer, Thomas Ritter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2015
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic ApplicationsSweta Rani, Aideen E Ryan, Matthew D Griffin, et al.
Pageof 12